Table 1.
Clinical information of patients included in current study and their tumor characteristics.
| Cohort I | N = 44 primary and 44 LNM | % |
|---|---|---|
| Age, y | ||
| Median age | 52 y | |
| Range | 32–74 y | |
| Gender | ||
| Female | 44 | 100% |
| Stage | ||
| I | 0 | 00.0% |
| II | 25 | 56.8% |
| III | 14 | 31.8% |
| IV | 5 | 11.4.0% |
| Molecular subtype | ||
| Luminal | 37 | 84.0% |
| HER2 | 3 | 06.8% |
| TN | 4 | 09.0% |
| Hormone status | ||
| ER | 36 | 81.8% |
| PR | 33 | 75.0% |
| HER2 | 10 | 22.7% |